Department of Microbiology, New York University School of Medicine, New York, NY, USA.
Cell Cycle. 2011 Jul 1;10(13):2064-8. doi: 10.4161/cc.10.13.16242.
The cellular protein synthesis machinery is tightly regulated and capable of rapid reaction to a variety of physiological inputs critical in stress-response, cell cycle control, cancer biology, and virus infection. One important strategy for stimulating protein synthesis involves the ser/thr kinase Akt, which subsequently triggers inactivation of the cap-dependent translational repressor 4E-BP1 by an mTOR-containing protein complex (mTORC1). A recent paper demonstrated that herpes simplex virus utilizes a remarkable tactic to activate mTOR in infected cells. Instead of using the cellular Akt, the virus produces a ser / thr kinase called Us3 that doesn't look like Akt, but masquerades as Akt. By making the Akt-like protein unrecognizable, this disguise allows it to bypass the strict limits normally imposed on the real cellular Akt. Importantly, preventing the virus Akt-imposter from triggering mTORC1 inhibited viral growth, suggesting a new way to block herpes simplex virus. This study also raises the possibility that other Akt-impersonators may lurk hidden in our own genomes, possibly contributing to diseases ranging from diabetes to cancer.
细胞蛋白合成机制受到严格调控,能够对各种生理输入做出快速反应,这些输入在应激反应、细胞周期控制、癌症生物学和病毒感染中至关重要。刺激蛋白质合成的一个重要策略涉及丝氨酸/苏氨酸激酶 Akt,该激酶随后通过含有 mTOR 的蛋白复合物(mTORC1)触发帽依赖性翻译抑制剂 4E-BP1 的失活。最近的一篇论文表明,单纯疱疹病毒利用一种显著的策略来激活感染细胞中的 mTOR。病毒不是使用细胞 Akt,而是产生一种称为 Us3 的丝氨酸/苏氨酸激酶,它看起来不像 Akt,但伪装成 Akt。通过使 Akt 样蛋白无法识别,这种伪装使其能够绕过通常对真正的细胞 Akt 施加的严格限制。重要的是,阻止病毒 Akt 冒名顶替者触发 mTORC1 抑制了病毒的生长,这为阻断单纯疱疹病毒提供了一种新方法。这项研究还提出了一种可能性,即其他 Akt 冒名顶替者可能隐藏在我们自己的基因组中,可能导致从糖尿病到癌症等各种疾病。